Trial Outcomes & Findings for Usefulness of BiClamp Forceps for Liver Resection: A Randomized Clinical Trial (NCT NCT02197481)

NCT ID: NCT02197481

Last Updated: 2017-12-14

Results Overview

Blood loss during operation. Blood loss was calculated from the beginning to the end of operation The amount of blood loss was measured from the suction volume after subtraction of rinse fluids and from the weight of soaked gauzes that were used during transection

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

105 participants

Primary outcome timeframe

an expected average of 80 minutes

Results posted on

2017-12-14

Participant Flow

Eligibility criteria included scheduled liver resection for benign or malignant hepatobiliary disease and a minimum age of 18 years.

Patients undergoing concomitant vascular resection or bile duct resection and those undergoing emergency liver resection were excluded.

Participant milestones

Participant milestones
Measure
Clamp-Crushing Technique
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electric knife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
Overall Study
STARTED
43
43
Overall Study
COMPLETED
43
43
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Usefulness of BiClamp Forceps for Liver Resection: A Randomized Clinical Trial

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Clamp-Crushing Technique
n=43 Participants
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 Participants
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
Total
n=86 Participants
Total of all reporting groups
Age, Continuous
53.12 years
STANDARD_DEVIATION 10.84 • n=5 Participants
55.98 years
STANDARD_DEVIATION 11.30 • n=7 Participants
54.55 years
STANDARD_DEVIATION 11.10 • n=5 Participants
Sex: Female, Male
Female
16 Participants
n=5 Participants
23 Participants
n=7 Participants
39 Participants
n=5 Participants
Sex: Female, Male
Male
27 Participants
n=5 Participants
20 Participants
n=7 Participants
47 Participants
n=5 Participants
Region of Enrollment
China
43 participants
n=5 Participants
43 participants
n=7 Participants
86 participants
n=5 Participants
Transection surface area
69.11 cm2
STANDARD_DEVIATION 40.09 • n=5 Participants
65.16 cm2
STANDARD_DEVIATION 44.30 • n=7 Participants
67.14 cm2
STANDARD_DEVIATION 42.04 • n=5 Participants
Specimen weight
230.73 g
STANDARD_DEVIATION 191.35 • n=5 Participants
193.25 g
STANDARD_DEVIATION 182.48 • n=7 Participants
211.99 g
STANDARD_DEVIATION 186.82 • n=5 Participants

PRIMARY outcome

Timeframe: an expected average of 80 minutes

Blood loss during operation. Blood loss was calculated from the beginning to the end of operation The amount of blood loss was measured from the suction volume after subtraction of rinse fluids and from the weight of soaked gauzes that were used during transection

Outcome measures

Outcome measures
Measure
Clamp-Crushing Technique
n=43 Participants
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 Participants
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
The Total Blood Loss
376.73 ml
Standard Deviation 303.67
339.81 ml
Standard Deviation 257.20

SECONDARY outcome

Timeframe: an expected average of 40 minutes

liver transection time was calculated from the beginning to the end of the liver resection

Outcome measures

Outcome measures
Measure
Clamp-Crushing Technique
n=43 Participants
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 Participants
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
Liver Transection Time
25.51 min
Standard Deviation 12.19
26.21 min
Standard Deviation 17.17

SECONDARY outcome

Timeframe: 90 days

Operative mortality was defined as any death resulting from a complication during surgery

Outcome measures

Outcome measures
Measure
Clamp-Crushing Technique
n=43 Participants
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 Participants
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
Mortality
0 participants
0 participants

SECONDARY outcome

Timeframe: 90 days

Outcome measures

Outcome measures
Measure
Clamp-Crushing Technique
n=43 Participants
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 Participants
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
Morbidity
13 participants
12 participants

SECONDARY outcome

Timeframe: 90 days

Biliary leakage was documented in line with the International Study Group of Liver Surgery (ISGLS) definitions and grading systems

Outcome measures

Outcome measures
Measure
Clamp-Crushing Technique
n=43 Participants
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 Participants
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
Biliary Leakage
4 participants
2 participants

SECONDARY outcome

Timeframe: an expected average of 12 days

Time from day of operation to day of discharge

Outcome measures

Outcome measures
Measure
Clamp-Crushing Technique
n=43 Participants
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 Participants
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
Duration of Postoperative Hospital Stay
8.65 days
Standard Deviation 2.02
8.81 days
Standard Deviation 2.49

SECONDARY outcome

Timeframe: 2 days

Administration of blood transfusions is documented for the intraoperative and postoperative period until 48 hours postoperatively

Outcome measures

Outcome measures
Measure
Clamp-Crushing Technique
n=43 Participants
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 Participants
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
Number of Participants Requiring a Blood Transfusion
2 participants
4 participants

SECONDARY outcome

Timeframe: 3 postoperative day

serum total bilirubin on 3 postoperative day (umol/L)

Outcome measures

Outcome measures
Measure
Clamp-Crushing Technique
n=43 Participants
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 Participants
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
Total Bilirubin
17.70 umol/l
Standard Deviation 11.34
18.46 umol/l
Standard Deviation 17.75

Adverse Events

Clamp-Crushing Technique

Serious events: 4 serious events
Other events: 12 other events
Deaths: 0 deaths

BiClamp Forceps Hepatectomy

Serious events: 2 serious events
Other events: 12 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Clamp-Crushing Technique
n=43 participants at risk
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 participants at risk
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
Hepatobiliary disorders
biliary leakage
7.0%
3/43 • Number of events 43
2.3%
1/43 • Number of events 43
General disorders
pleural effusions
2.3%
1/43 • Number of events 1
2.3%
1/43 • Number of events 1

Other adverse events

Other adverse events
Measure
Clamp-Crushing Technique
n=43 participants at risk
liver transection during hepatectomy by the routine clamp-crushing technical without BiClamp forceps assisted Clamp-Crushing technique: Liver transection during hepatectomy by monopole electronicknife and blood vessel forceps, but without BiClamp forceps
BiClamp Forceps Hepatectomy
n=43 participants at risk
The BiClamp forceps, a reusable bipolar sealing instrument for use in open surgery, was uniformly employed in all patients randomized to BiClamp forcep hepatectomy group in the present study. BiClamp forceps: liver transection during hepatectomy by BiClamp forceps
General disorders
pleural effusions
16.3%
7/43 • Number of events 7
16.3%
7/43 • Number of events 7
Hepatobiliary disorders
Liver failure
4.7%
2/43 • Number of events 2
4.7%
2/43 • Number of events 2
Infections and infestations
Wound infection
4.7%
2/43 • Number of events 2
4.7%
2/43 • Number of events 2
Hepatobiliary disorders
Biliary leakage
2.3%
1/43 • Number of events 1
2.3%
1/43 • Number of events 1

Additional Information

Dr.Jiang-ming Chen

The Second Affiliated Hospital of Anhui Medical University

Phone: 15855518651

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place